OpenBench - About the company
OpenBench is a seed company based in San Francisco (United States), founded in 2019 by Jim Thompson and James Yoder. It operates as an AI-based virtual drug screening technology for researchers. OpenBench has raised $2.57M in funding. The company has 180 active competitors, including 42 funded and 19 that have exited. Its top competitors include companies like HotSpot Therapeutics, Cartography Biosciences and GRO Biosciences.
Company Details
AI-based virtual drug screening technology for researchers. The company has developed a small molecule drug discovery tool that enables reachers to predict molecular properties for drug discovery. It has features for data engineering, data curation, and more.
- Website
- opnbnch.com
- Social
- Email ID
- *****@opnbnch.com
Key Metrics
Founded Year
2019
Location
San Francisco, United States
Stage
Seed
Total Funding
$2.57M in 2 rounds
Latest Funding Round
Ranked
37th among 180 active competitors
Employee Count
7 as on Mar 31, 2026
Similar Companies
Legal entities associated with OpenBench
OpenBench is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
OpenBench, Inc. CIN: 320614815 , United States, Active | Jan 28, 2020 | - | 6 (As on Dec 31, 2024) | - |
Sign up to download OpenBench's company profile
OpenBench's funding and investors
OpenBench has raised a total funding of $2.57M over 2 rounds. Its first funding round was on Jan 13, 2020.
Here is the list of recent funding rounds of OpenBench:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 08, 2022 | 4114020 | Seed | 4131758 | 1131276 | 7490051 | 9320044 |
Jan 13, 2020 | 9888354 | Seed | 5224649 | 9589675 | 3103545 | 1777468 |
Access funding benchmarks and valuations. Sign up today!View details of OpenBench's funding rounds and investors
OpenBench's founders and board of directors
Founder? Claim ProfileThe founders of OpenBench are Jim Thompson and James Yoder.
Here are the details of OpenBench's key team members:
- Jim Thompson: Co-Founder & CEO of OpenBench. Contact Info: 1 email address
- James Yoder: Co-Founder & CTO of OpenBench. Contact Info: 1 email address
View details of OpenBench's Founder profiles and Board Members
OpenBench's employee count trend
OpenBench has 7 employees as of Mar 26. Here is OpenBench's employee count trend over the years:
Uncover OpenBench's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OpenBench's Competitors and alternates
Top competitors of OpenBench include HotSpot Therapeutics, Cartography Biosciences and GRO Biosciences. Here is the list of Top 10 competitors of OpenBench, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  HotSpot Therapeutics 2017, Boston (United States), Series C | Developer of a platform for protein function analysis | $210M | 64/100 | |
2nd |  Cartography Biosciences 2020, Foster City (United States), Series B | Provider of a platform to discover immunotherapeutics | $124M | 61/100 | |
3rd |  GRO Biosciences 2016, Boston (United States), Series B | Developer of re-coding synthetic biology tools | $91.1M | 60/100 | |
4th |  TOLREMO therapeutics 2017, Zurich (Switzerland), Series A | Developing anti-cancer small molecules targeting novel drug resistance pathways | $55.8M | 60/100 | |
5th |  Recludix Pharma 2020, San Diego (United States), Series A | Provider of the online platform for drug discovery and development | $60M | 60/100 | |
6th | Certara 2008, Princeton (United States), Public | Provider of a platform for in silico drug discovery and consulting services | - | 59/100 | |
7th | Oxford Drug Design 2001, Oxford (United Kingdom), Series A | Provider of computer-aided design of antibiotics for MDR infections | $12.4M | 59/100 | |
8th |  Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 58/100 | |
9th | CytoReason 2016, Haifa (Israel), Series C | Discovering immune system based drugs by biological data analytics | $130M | 56/100 | |
10th | Genialis 2015, Boston (United States), Series A | Developer of end-to-end bioinformatics software solutions | $16M | 56/100 | |
37th |  OpenBench 2019, San Francisco (United States), Seed | AI-based virtual drug screening technology for researchers | $2.57M | - | 33/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on OpenBench's competitors? Click here to see the top ones
OpenBench's Investments and acquisitions
OpenBench has made no investments or acquisitions yet.
Reports related to OpenBench
Here is the latest report on OpenBench's sector:
News related to OpenBench
•
858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery CollaborationFinancial Post•Nov 04, 2024•858 Therapeutics, OpenBench
•
•
Tavros and OpenBench expand small molecule drug discovery alliancePharmaceutical Technology•Apr 28, 2023•Tavros, OpenBench
•
Tavros Therapeutics and OpenBench Expand Strategic Collaboration for Small Molecule Drug DiscoveryGlobeNewswire•Apr 27, 2023•Tavros, OpenBench
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about OpenBench
Explore our recently published companies
- AIPL ABRO - Delhi based, 2010 founded, Unfunded company
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Vallabh Pumps - Indore based, Unfunded company
